Hi-Tech Pharmacal (HITK) Shares Dip Midday Following Needham Downgrade

Shares of Hi-Tech Pharmacal (NASDAQ: HITK) edged lower during Monday's afternoon session following a mid-day downgrade from Needham & Company.

The firm now rates Hi-Tech shares a Hold, down from Buy previously.

The stock is down more than 8 percent this afternoon despite strong Q2 results from the company this morning.

For an analyst ratings summary and ratings history on Hi Tech Pharmacal click here. For more ratings news on Hi Tech Pharmacal click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• Lockheed Martin (LMT) PT Raised to $581 at UBS on Revenue Growth Momentum
• RMX Industries executes 1-for-3 reverse stock split on OTCQB